Apr 17, 2019
Type 2 diabetes contributes directly to many serious comorbidities: one of the most important of these is kidney failure worldwide. A large, industry-sponsored double-blind, randomized trial has recently assessed the impact of canagliflozin upon albuminuric chronic...
Apr 15, 2019
There continues to be fierce debate about the value of dietary supplements, particularly in the context of developed nations where nutrient intake should be adequate. The issue has recently been addressed in a prospective cohort study from the USA. The investigators...
Apr 15, 2019
An international study has recently investigated the incidence of new onset type 2 diabetes mellitus amongst men treated with dutasteride, finasteride or tamsulosin for long term treatment of benign prostatic hyperplasia. The subjects received dutasteride (n=8231),...
Apr 13, 2019
Medications can be implicated as a cause of movement disorders, examples of clinically important syndromes include tremor, akathisia, parkinsonism and dyskinesia. An excellent review has recently been published in the Australian Prescriber, and can be viewed...
Apr 12, 2019
Can input from clinical pharmacist interventions impact upon length of hospital stay (LOS)? Recently published research suggests so. A high-quality study evaluated the impact of pharmacist-driven interventions on LOS across three practice areas (medicine,...
